Link Spine Group Licenses Numoda SuperPlatform™
to Speed Important New Medical Devices to Market
May 2, 2002
PHILADELPHIA, May 2 - It was announced today that Link Spine Group
will bring exciting new disc replacement therapies to market much faster,
thanks to information technology instruments created on the Numoda Corporation
SuperPlatform.
For any new medical device to come to market it must successfully complete
an expensive and lengthy investigative process of clinical studies. Numoda's
latest data collection instruments will save months of data cleaning due
to unique capabilities. These mobile wireless applications match the users'
(surgeons, investigators and coordinators) workflow process. They ensure
that the correct data is entered in the right sequence, at the correct
intervals and guide the user to precisely what needs to be collected.
They alert the user when to go ahead, and they ensure the mandatory data
is collected, virtually eliminating the data query process.
Only the Numoda SuperPlatform, built to handle the complex information
technology demands of the pharmaceutical industry, can provide this and
deliver the laboratory data directly into the hands of the users, instantly.
The Numoda system is much more reliable, cost-effective, efficient and
delivers better data than is possible with web-based systems. The powerful,
broad functionality of the platform, with easy-to-use instruments, saves
numerous steps and time. Data is entered at the point it is generated,
right -- first time. This means that the minute the data is collected
it is available for analysis, and the minute the trial ends it is available
for submission. This saves months of clean-up of the database.
As Clinical Research Director Joyce Maga of Link Spine Group says, "With
the Numoda system cleaning the database as you go, when you're done, you're
done." This is of great benefit for those companies without extensive
data management or IT resources. And of course, huge amounts of paper
and filing costs are saved. From a business perspective, President and
Chief Executive Officer Brian Cameron of Link Spine Group says, "Every
day saved in the investigative process means a day sooner that patients
will receive this valuable therapy."
About Numoda Corporation
Numoda Corporation provides information technologies for drug development
and marketing, patient diaries, and ongoing patient monitoring, which
significantly reduce the time and cost to bring products to market. Numoda
designs, develops and deploys Electronic Data Collection systems for any
handheld device, tablet, notebook, etc. across any telecommunications
network, wireless or wire line. The difference is the Numoda SuperPlatform(TM)
-- a mobile and wireless data collection and data management technology
that outperforms web-based EDC and other data collection methods. The
Numoda SuperPlatform for Life Sciences is the only information technology
licensed by the pharmaceutical industry that maximizes research and development,
links information across all phases of trials, commercializes important
findings globally, and delivers faster, more accurate results at substantially
lower costs.
About Link Spine Group
Link Spine Group Inc. is focused on providing non-fusion technology and
an innovative surgical procedure to spine surgeons for treating patients
with degenerative disc disease and related conditions of the lumbar spine
by offering a total disc replacement -- the CHARITÉ™ Artifical Disc.
DePuy Spine's CHARITÉ™ Artifical Disc is an investigational device limited
by US (Federal) law to
investigational use in the USA. The SB CHARITÉ™ Artifical
Disc has received the CE mark and is commercially available outside of
the United States
in over 25
countries throughout Europe, Asia, Canada, Australia, Africa and Latin
America.
